Only three (17%) of 18 men who were diagnosed with on-protocol prostate cancer reported urinary symptoms before diagnosis (two MSH2 carriers and one MSH6 carrier) and five (28%) had previously had a PSA test before study entry (four MSH2 carriers and one MSH6 carrier; table 4). The gene discussed is MSH6; the disease is Familial prostate cancer.